FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Testosterone 100 mg prolonged-release subcutaneous implant Count of base of active ingredient False 1 Inferred relationship Some
    Testosterone 100 mg prolonged-release subcutaneous implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Buprenorphine 20 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Buprenorphine 10 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Hydrogen peroxide 350 mg/mL oropharyngeal solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Hydrogen peroxide 350 mg/mL oropharyngeal solution Count of base of active ingredient False 1 Inferred relationship Some
    Testosterone 200 mg prolonged-release subcutaneous implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Testosterone 200 mg prolonged-release subcutaneous implant Count of base of active ingredient False 1 Inferred relationship Some
    Dexamethasone 700 microgram prolonged-release ocular implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Dexamethasone 700 microgram prolonged-release ocular implant Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely methylprednisolone 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely methylprednisolone 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely methylprednisolone 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Diclofenac potassium 50 mg powder for oral solution sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Diclofenac potassium 50 mg powder for oral solution sachet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Varicella-zoster virus antibody 104 unit/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Varicella-zoster virus antibody 104 unit/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Heparin (as porcine heparin sodium) 100 unit/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Heparin (as porcine heparin sodium) 100 unit/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon beta-1a 24 million unit/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Interferon beta-1a 24 million unit/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Heparin (as porcine heparin sodium) 10 unit/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Heparin (as porcine heparin sodium) 10 unit/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3

    Start Previous Page 186 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start